1. Armstrong, D. 1980. Infections in patients with neoplastic disease. p. 129–158.In J. Verhoef, P. K. Peterson and P. G. Quie (eds), Infections in the Immunocompromised Host; Pathogenesis, Prevention and Therapy. — Elsevier/North Holland, Amsterdam.
2. Braude, A. I., Ziegler, E. J., Douglas, H. andMcCutchan, J. A. 1977. Antibody to cell wall glycolipid of gram-negative bacteria: induction of immunity to bacteremia and endotoxemia. — J. Infect. Dis.136 (suppl.): S167-S173.
3. Costerton, J. W., Ingram, J. M. andCheng, K.-J. 1974. Structure and function of the cell envelope of gram-negative bacteria. — Bacteriol. Rev.38: 87–110.
4. Dekker, A. W., Rozenberg-Arska, M., Sixma, J. J. andVerhoef, J. 1981. Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphoblastic leukemia. — Ann. Intern. Med.95: 555–559.
5. Galanos, C., Lüderitz, O., Rietschel, E. T. andWestphal, O. 1977. Newer aspects of the chemistry and biology of bacterial lipopolysaccharides, with special reference to their lipid A component. p. 239–386.In T. W. Goodwin (ed.), Int. Rev. Biochem., Vol. 14. — University Park Press, Baltimore.